Green J - Search Results

1

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.

Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins GJ, Zannettino AC. Pan B, et al. Among authors: green j. Bone. 2004 Jan;34(1):112-23. doi: 10.1016/j.bone.2003.08.013. Bone. 2004. PMID: 14751568

2

The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).

Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC. Pan B, et al. Among authors: green j. J Bone Miner Res. 2004 Jan;19(1):147-54. doi: 10.1359/jbmr.2004.19.1.147. J Bone Miner Res. 2004. PMID: 14753746 Free article.

3

Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.

Croucher PI, De Hendrik R, Perry MJ, Hijzen A, Shipman CM, Lippitt J, Green J, Van Marck E, Van Camp B, Vanderkerken K. Croucher PI, et al. Among authors: green j. J Bone Miner Res. 2003 Mar;18(3):482-92. doi: 10.1359/jbmr.2003.18.3.482. J Bone Miner Res. 2003. PMID: 12619933 Free article.

4

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.

Hadji P, Coleman R, Gnant M, Green J. Hadji P, et al. Among authors: green j. Ann Oncol. 2012 Nov;23(11):2782-2790. doi: 10.1093/annonc/mds169. Epub 2012 Jun 22. Ann Oncol. 2012. PMID: 22730099 Free PMC article. Review.

5

Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys.

Binkley N, Kimmel D, Bruner J, Haffa A, Davidowitz B, Meng C, Schaffer V, Green J. Binkley N, et al. Among authors: green j. J Bone Miner Res. 1998 Nov;13(11):1775-82. doi: 10.1359/jbmr.1998.13.11.1775. J Bone Miner Res. 1998. PMID: 9797488 Free article.

6

The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage.

Muehleman C, Green J, Williams JM, Kuettner KE, Thonar EJ, Sumner DR. Muehleman C, et al. Among authors: green j. Osteoarthritis Cartilage. 2002 Mar;10(3):226-33. doi: 10.1053/joca.2001.0506. Osteoarthritis Cartilage. 2002. PMID: 11869084 Free article.

7

Bisphosphonates: new therapeutic agents for the treatment of bone tumors.

Heymann D, Ory B, Gouin F, Green JR, Rédini F. Heymann D, et al. Trends Mol Med. 2004 Jul;10(7):337-43. doi: 10.1016/j.molmed.2004.05.007. Trends Mol Med. 2004. PMID: 15242682 Review.

8

An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates.

Thiébaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P. Thiébaud D, et al. Among authors: green jr. Calcif Tissue Int. 1997 Nov;61(5):386-92. doi: 10.1007/s002239900353. Calcif Tissue Int. 1997. PMID: 9351880 Clinical Trial.

9

Prevention of strain-related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate.

Goodship AE, Blunn GW, Green J, Coathup MJ. Goodship AE, et al. Among authors: green j. J Orthop Res. 2008 May;26(5):693-703. doi: 10.1002/jor.20533. J Orthop Res. 2008. PMID: 18050308 Free article.

10

Zoledronate: the preclinical pharmacology.

Green J. Green J. Br J Clin Pract Suppl. 1996 Sep;87:16-8; discussion 22. Br J Clin Pract Suppl. 1996. PMID: 8995013 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,137 results

Search Page

Filters